Arrowhead Pharmaceuticals grants up to 196,885 restricted stock units to 203 new employees
- Arrowhead Pharmaceuticals awarded 203 new employees grants totaling up to 196,885 restricted stock units.
- Approved on October 22, 2026, the grants vest annually over four years outside stockholder-approved equity incentive plans.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arrowhead Pharmaceuticals Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261117209500) on November 17, 2026, and is solely responsible for the information contained therein.